권호기사보기
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
---|---|---|---|---|---|---|---|---|---|
연구/단체명을 입력해주세요. |
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
Title Page
ABSTRACT
Contents
I. INTRODUCTION 12
II. MATERIALS AND METHODS 20
A. Chemicals and antibodies 20
B. Constructs 20
C. Animals 22
D. Cell culture 23
E. Transfection 23
F. Tissue & Cell sample preparation 24
G. Immunoblot analysis 25
H. Immunohistochemistry 25
I. Immunocytochemistry 26
J. Reverse transcription polymerase chain reaction (RT-PCR) 27
K. Statistical analysis 28
III. RESULTS 29
1. Circadian rhythm was disrupted in P301S mutant human tau transgenic mice 29
2. Circadian disruption was observed also in the cortex and hippocampus of P301S tau transgenic mice 34
3. The status of pathologic tau was altered according to ZT 40
4. Oscillations of tau solubility was relevant to the chaperon Hsp70 protein 43
5. Bmal1 modulated tau status and stability via Hsp70 upregulation 48
6. Hsp70 was involved in the modulation of tau status and stability 54
IV. DISCUSSION 62
V. REFERENCES 70
국문 요약 76
Figure 1. The circadian rhythm-related physiology. 17
Figure 2. The molecular mechanism of circadian clock. 18
Figure 3. The formation of neurofibrillary tangles (NFTs) in tauopathies. 19
Figure 4. Full picture for drawing ROI of SCN. 31
Figure 5. Circadian rhythm expressions of master clock molecules in... 32
Figure 6. Transcription levels of circadian oscillators in diencephalon... 33
Figure 7. Disrupted rhythmicity of core clock genes in the cortex of... 37
Figure 8. Disrupted rhythmicity of core clock genes in the... 39
Figure 9. ZT-related alteration of pathologic tau status. 41
Figure 10. Densitometry analysis of pathologic tau status. 42
Figure 11. The diurnal alteration of Hsp70. 44
Figure 12. Oscillations of tau solubility relevant to the chaperon Hsp70 protein. 45
Figure 13. Reverse correlation between the insoluble tau and Hsp70. 46
Figure 14. Co-localization of Hsp70 and tau. 47
Figure 15. Tau-aggregation enhanced by forskolin treatment. 50
Figure 16. Increase in Hsp70 by overexpression of Bmal1. 51
Figure 17. Bmal1 regulates mutant tau status as well as its... 52
Figure 18. Degradation of mutant tau by Bmal1 was mediated by HSF1... 53
Figure 19. Hsp70-mediated tau disaggregation and following its degradation. 56
Figure 20. No alteration of Tau mRNA levels by Hsp70. 57
Figure 21. Co-localization of Hsp70 and tau in tau overexpressing... 58
Figure 22. Involvement of autophagy and proteasome in Hsp70-... 59
Figure 23. The regulation of tau degradation by Bmal1-Hsp70. 60
Figure 24. Disaggregation of tau prior to its degradation mediated by Hsp70. 61
Figure 25. Hypothetical model for the interrelation mechanism... 63
Figure 26. Prediction of Bmal1 binding on the promoter region of Hsp70. 65
Figure 27. Hsc70, a possible another downstream target of Bmal1. 66
*표시는 필수 입력사항입니다.
*전화번호 | ※ '-' 없이 휴대폰번호를 입력하세요 |
---|
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.